Digital News Report – The U.S. Food and Drug Administration (FDA) approved the cholesterol lowering drug Crestor for healthy people. Doctors may begin prescribing the drug to prevent or reduce the risk of stroke, heart attack and other heart ailments.
This new “indication” has sparked debate in the medical community. Some may recommend the drug to men over the age of 50 and women over the age of 60 without high blood pressure but elevated levels of C-reactive protein.
The C-reactive protein is an inflation marker. Patients with this marker are more likely to develop heard disease and high blood pressure.
By: Jason Chang
|
